The Startup That Helps You Pay Off Your Student Loans...
Charting The Collapse of the Middle Class in 20 Major US Cities
Are Emerging Markets Getting Their Mojo Back?
Why the Smart Money Is Piling Into Regenerative Medicine
The 3 Types Of Life-Changing Crisis That Is Good for Gold
Dr. Daniel Teper, CEO of Immune Pharmaceuticals, Inc. (NASDAQ: IMNP) sits down with Equities.com's Sasha Salama to discuss the company's major milestones and catalysts.
You have to be logged in to leave a comment.
I'm sorry, but in order to complete what you're trying to do, you must be logged in.
© 2017 Equities
* All dates and time are being displayed in Eastern Standard Time (EST).